Published in PLoS Comput Biol on November 01, 2007
The cancer genome. Nature (2009) 23.13
Clonal evolution in cancer. Nature (2012) 11.07
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A (2010) 4.47
Evolution of the cancer genome. Nat Rev Genet (2012) 3.24
Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci U S A (2013) 3.15
The (un)targeted cancer kinome. Nat Chem Biol (2010) 2.33
Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci U S A (2013) 2.23
TGF-β: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst (2014) 2.08
Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis. Nat Genet (2011) 2.02
Mutational heterogeneity in human cancers: origin and consequences. Annu Rev Pathol (2010) 2.02
Design and analysis issues in genome-wide somatic mutation studies of cancer. Genomics (2008) 1.95
DNA replication fidelity and cancer. Semin Cancer Biol (2010) 1.69
Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia. Cancer Prev Res (Phila) (2012) 1.66
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. Nature (2015) 1.66
What does physics have to do with cancer? Nat Rev Cancer (2011) 1.59
Defining the blueprint of the cancer genome. Carcinogenesis (2008) 1.49
Roles for growth factors in cancer progression. Physiology (Bethesda) (2010) 1.48
NCI's provocative questions on cancer: some answers to ignite discussion. Oncotarget (2011) 1.42
A Molecular Clock Infers Heterogeneous Tissue Age Among Patients with Barrett's Esophagus. PLoS Comput Biol (2016) 1.38
Cancer evolution: mathematical models and computational inference. Syst Biol (2014) 1.36
Intratumor heterogeneity in evolutionary models of tumor progression. Genetics (2011) 1.31
The stochastic edge in adaptive evolution. Genetics (2008) 1.30
Molecular damage in cancer: an argument for mTOR-driven aging. Aging (Albany NY) (2011) 1.29
Systemic buffers inhibit carcinogenesis in TRAMP mice. J Urol (2012) 1.28
Technology-specific error signatures in the 1000 Genomes Project data. Hum Genet (2011) 1.27
Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing. Nucleic Acids Res (2009) 1.26
Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res (Phila) (2011) 1.21
The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One (2011) 1.20
A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates. BMC Cancer (2010) 1.16
Advances for studying clonal evolution in cancer. Cancer Lett (2013) 1.14
Microenvironmental independence associated with tumor progression. Cancer Res (2009) 1.13
Our changing view of the genomic landscape of cancer. J Pathol (2010) 1.13
Impact of tumor progression on cancer incidence curves. Cancer Res (2012) 1.13
Thyroid Growth and Cancer. Eur Thyroid J (2015) 1.11
Public goods in relation to competition, cooperation, and spite. Proc Natl Acad Sci U S A (2014) 1.09
A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis. PLoS Comput Biol (2012) 1.07
Dynamics of targeted cancer therapy. Trends Mol Med (2012) 1.07
Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics. Cancer Biol Ther (2010) 1.06
Models of carcinogenesis: an overview. Carcinogenesis (2010) 1.05
Evolutionary dynamics of tumor progression with random fitness values. Theor Popul Biol (2010) 1.05
Pathways to tumorigenesis--modeling mutation acquisition in stem cells and their progeny. Neoplasia (2008) 1.04
Modelling the evolution of genetic instability during tumour progression. Evol Appl (2012) 1.04
The pace of evolution across fitness valleys. J Theor Biol (2009) 1.04
Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome. Oncogene (2011) 1.04
The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway. Genes Dev (2012) 1.04
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology. J Mol Diagn (2015) 1.04
Spatial structure increases the waiting time for cancer. New J Phys (2011) 1.02
Germline fitness-based scoring of cancer mutations. Genetics (2011) 1.02
Cell selection as driving force in lung and colon carcinogenesis. Cancer Res (2010) 1.01
Solutions to Peto's paradox revealed by mathematical modelling and cross-species cancer gene analysis. Philos Trans R Soc Lond B Biol Sci (2015) 1.00
Somatic variation and cancer: therapies lost in the mix. Hum Genet (2011) 0.99
MtDNA mutation pattern in tumors and human evolution are shaped by similar selective constraints. Genome Res (2009) 0.98
Protein domain-level landscape of cancer-type-specific somatic mutations. PLoS Comput Biol (2015) 0.97
Galectin-4 functions as a tumor suppressor of human colorectal cancer. Int J Cancer (2010) 0.96
A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data. Genome Biol (2014) 0.96
Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes. Hum Genet (2011) 0.96
Peto's paradox and the promise of comparative oncology. Philos Trans R Soc Lond B Biol Sci (2015) 0.94
The real war on cancer: the evolutionary dynamics of cancer suppression. Evol Appl (2012) 0.93
Stochastic dynamics of cancer initiation. Phys Biol (2011) 0.91
The effect of one additional driver mutation on tumor progression. Evol Appl (2012) 0.90
Bioinformatics for cancer immunology and immunotherapy. Cancer Immunol Immunother (2012) 0.90
Elevated tolerance to aneuploidy in cancer cells: estimating the fitness effects of chromosome number alterations by in silico modelling of somatic genome evolution. PLoS One (2013) 0.90
Molecular and genetic aspects of odontogenic tumors: a review. Iran J Basic Med Sci (2015) 0.88
Stem vs non-stem cell origin of colorectal cancer. Br J Cancer (2015) 0.87
The mini-driver model of polygenic cancer evolution. Nat Rev Cancer (2015) 0.87
A deterministic model for the occurrence and dynamics of multiple mutations in hierarchically organized tissues. J R Soc Interface (2013) 0.87
Natural resistance to cancers: a Darwinian hypothesis to explain Peto's paradox. BMC Cancer (2012) 0.87
Determinants of polyp size in patients undergoing screening colonoscopy. BMC Gastroenterol (2011) 0.86
Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution. PLoS Comput Biol (2016) 0.86
Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction. BMC Cancer (2015) 0.85
The protective role of symmetric stem cell division on the accumulation of heritable damage. PLoS Comput Biol (2014) 0.84
Multifocality and recurrence risk: a quantitative model of field cancerization. J Theor Biol (2014) 0.84
A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers. PLoS One (2014) 0.84
Should tissue structure suppress or amplify selection to minimize cancer risk? Biol Direct (2016) 0.84
Genomic instability and carcinogenesis: an update. Curr Genomics (2008) 0.84
Effect of dedifferentiation on time to mutation acquisition in stem cell-driven cancers. PLoS Comput Biol (2014) 0.83
Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon. BMC Cancer (2012) 0.83
An evolutionary explanation for the presence of cancer nonstem cells in neoplasms. Evol Appl (2012) 0.82
Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer. Br J Cancer (2012) 0.82
Hypoxia and regulation of cancer cell stemness. Adv Exp Med Biol (2014) 0.81
Lowly expressed ribosomal protein s19 in the feces of patients with colorectal cancer. ISRN Gastroenterol (2012) 0.80
New models of neoplastic progression in Barrett's oesophagus. Biochem Soc Trans (2010) 0.80
Evolution of pre-existing versus acquired resistance to platinum drugs and PARP inhibitors in BRCA-associated cancers. PLoS One (2014) 0.80
Evolutionary dynamics of chronic myeloid leukemia. Genes Cancer (2010) 0.80
Family cancer syndromes: inherited deficiencies in systems for the maintenance of genomic integrity. Surg Oncol Clin N Am (2009) 0.79
Fixation times in differentiation and evolution in the presence of bottlenecks, deserts, and oases. J Theor Biol (2015) 0.79
Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? Cancer Metastasis Rev (2013) 0.78
Evolutionary shift dynamics on a cycle. J Theor Biol (2012) 0.78
Effects of STAT3 gene silencing and rapamycin on apoptosis in hepatocarcinoma cells. Int J Med Sci (2012) 0.78
A deterministic analysis of genome integrity during neoplastic growth in Drosophila. PLoS One (2014) 0.77
Mutator/Hypermutable fetal/juvenile metakaryotic stem cells and human colorectal carcinogenesis. Front Oncol (2013) 0.77
Identifying restrictions in the order of accumulation of mutations during tumor progression: effects of passengers, evolutionary models, and sampling. BMC Bioinformatics (2015) 0.77
Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers. Clin Transl Med (2016) 0.77
Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical model. Front Genet (2015) 0.77
Mathematical models for translational and clinical oncology. J Clin Bioinforma (2013) 0.77
Modeling tumor evolutionary dynamics. Front Physiol (2013) 0.77
An argument for mechanism-based statistical inference in cancer. Hum Genet (2014) 0.77
Tumor Evolution: Linear, Branching, Neutral or Punctuated? Biochim Biophys Acta (2017) 0.77
The implications of small stem cell niche sizes and the distribution of fitness effects of new mutations in aging and tumorigenesis. Evol Appl (2016) 0.76
The hallmarks of cancer. Cell (2000) 113.05
The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
Cancer genes and the pathways they control. Nat Med (2004) 24.22
Genetic instabilities in human cancers. Nature (1998) 22.76
The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer (1954) 11.33
A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics. Stat Appl Genet Mol Biol (2005) 9.57
DNA replication fidelity. Annu Rev Biochem (2000) 7.29
DNA damage and repair. Nature (2003) 6.76
Dynamics of chronic myeloid leukaemia. Nature (2005) 6.63
A new theory on cancer-inducing mechanism. Br J Cancer (1953) 6.53
Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst (1981) 5.59
A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer (1957) 5.27
A mutator phenotype in cancer. Cancer Res (2001) 4.41
Beneficial mutation selection balance and the effect of linkage on positive selection. Genetics (2007) 3.75
Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A (2002) 3.64
The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A (2002) 3.46
THE RATES AND PATTERNS OF GROWTH OF 375 TUMORS OF THE LARGE INTESTINE AND RECTUM OBSERVED SERIALLY BY DOUBLE CONTRAST ENEMA STUDY (MALMOE TECHNIQUE). Am J Roentgenol Radium Ther Nucl Med (1963) 3.44
Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci U S A (2002) 3.25
The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer (2003) 3.21
Human cancers express a mutator phenotype. Proc Natl Acad Sci U S A (2006) 3.11
The solitary wave of asexual evolution. Proc Natl Acad Sci U S A (2003) 2.97
Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci (1998) 2.92
Dynamics of cancer progression. Nat Rev Cancer (2004) 2.64
The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A (1999) 2.41
Cancer genetics. Am J Med Genet (2002) 2.19
Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat Med (1999) 2.14
The traveling-wave approach to asexual evolution: Muller's ratchet and speed of adaptation. Theor Popul Biol (2007) 2.07
Stochastic dynamics of hematopoietic tumor stem cells. Cell Cycle (2007) 1.68
Dynamics of colorectal cancer. Semin Cancer Biol (2005) 1.50
How many mutations in a cancer? Am J Pathol (2002) 1.37
Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. Cancer Res (2000) 1.32
The stochastic edge in adaptive evolution. Genetics (2008) 1.30
Stochastic modelling of colon cancer: is there a role for genomic instability? Carcinogenesis (2006) 1.28
Immortal DNA strand cosegregation requires p53/IMPDH-dependent asymmetric self-renewal associated with adult stem cells. Cancer Res (2005) 1.16
Crypt dynamics and colorectal cancer: advances in mathematical modelling. Cell Prolif (2006) 1.14
Natural history of colorectal cancer. Am J Med (1999) 1.13
A nonlinear mathematical model of cell turnover, differentiation and tumorigenesis in the intestinal crypt. J Theor Biol (2006) 1.13
Fat and K-ras mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis (2004) 0.93
The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02
IDH1 and IDH2 mutations in gliomas. N Engl J Med (2009) 32.41
High frequency of mutations of the PIK3CA gene in human cancers. Science (2004) 27.94
Cancer genome landscapes. Science (2013) 25.33
Cancer genes and the pathways they control. Nat Med (2004) 24.22
Antibody neutralization and escape by HIV-1. Nature (2003) 21.48
International network of cancer genome projects. Nature (2010) 20.35
Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc Natl Acad Sci U S A (2003) 12.91
Improved survival in multiple myeloma and the impact of novel therapies. Blood (2007) 12.70
The colorectal microRNAome. Proc Natl Acad Sci U S A (2006) 11.59
Allelic variation in human gene expression. Science (2002) 11.42
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science (2010) 10.78
Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A (2008) 10.52
Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (2011) 10.26
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature (2012) 10.17
Quantitative analysis of culture using millions of digitized books. Science (2010) 9.86
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature (2002) 9.40
A simple rule for the evolution of cooperation on graphs and social networks. Nature (2006) 9.31
Using the transcriptome to annotate the genome. Nat Biotechnol (2002) 9.04
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell (2005) 7.87
The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther (2004) 7.82
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (2002) 7.46
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science (2009) 7.39
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A (2013) 6.88
Spontaneous giving and calculated greed. Nature (2012) 6.75
Dynamics of chronic myeloid leukaemia. Nature (2005) 6.63
The antisense transcriptomes of human cells. Science (2008) 6.29
Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci U S A (2011) 6.29
Winners don't punish. Nature (2008) 6.12
Quantifying the evolutionary dynamics of language. Nature (2007) 6.12
Development of personalized tumor biomarkers using massively parallel sequencing. Sci Transl Med (2010) 6.08
Evolutionary dynamics on graphs. Nature (2005) 6.05
The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Science (2007) 6.01